Mephenaqualone
From Wikipedia, the free encyclopedia
Pharmaceutical compound
| Identifiers | |
|---|---|
| |
| Chemical and physical data | |
| Formula | C22H18N2O2 |
| Molar mass | 342.398 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Mephenaqualone is an analogue of the sedative and hypnotic drug methaqualone which has been sold as a designer drug. It was reported in Germany in 2025 as a contributor to drug overdose cases but has otherwise been little studied. Anecdotal reports suggest it is significantly more potent than methaqualone with a potency similar to that of benzodiazepine derivatives, but no pharmacological data is available as yet.[1][2][3]
References
- ↑ Yurchenko R, Yurchenko L, Pavelets Y, Galetskaya I, Navitski M, Piatsetskaya A (July 2024). Psychoactive products market observation. Trend analysis. Recent trends in the field of psychoactive substance identification. p. 11.
- ↑ "450. Мефенаквалон Раздел I.A. Вещества с подтвержденной структурой" [Mephenaqualone Section I.A. Structure-Confirmed Substances]. AIPSIN (in Russian).
- ↑ "Warnmeldung. Lebensgefahr durch hochpotente synthetische Opioide in Bayern" [Warning. Life-threatening danger from highly potent synthetic opioids in Bavaria.] (PDF). Bayerische Akademie für Sucht-und Gesundheitsfragen [Bavarian Academy for Addiction and Health Issues] (in German). 2025.
| Alcohols | |
|---|---|
| Barbiturates |
|
| Benzodiazepines |
|
| Carbamates | |
| Flavonoids |
|
| Imidazoles | |
| Kava constituents | |
| Monoureides | |
| Neuroactive steroids |
|
| Nonbenzodiazepines |
|
| Phenols | |
| Piperidinediones | |
| Pyrazolopyridines | |
| Quinazolinones | |
| Volatiles/gases |
|
| Others/unsorted |
|